drugset / Trial / NCT07692451
Fosrolapitant and Palonosetron for the Prevention of Antibody-drug Conjugate-induced Nausea and Vomiting
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study is aimed to evaluate the efficacy and safety of Fosrolapitant and Palonosetron for Antibody-drug conjugate-induced nausea and vomiting
Timeline
- Start
- 2026-07-15
- Primary completion
- 2027-07-15
- Completion
- 2027-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fosaprepitant | Other / unclassified | — | — |
| Subject | Fosrolapitant | Small molecule | — | — |
| Subject | Palonosetron | Other / unclassified | — | — |
| Background | Dexamethasone | Small molecule | — | — |